NARI: Inari Medical Inc Company Profile & Statistics

About

Inari Medical, Inc. is a commercial-stage medical device company committed toward developing products to treat and change the lives of patients suffering from venous diseases. Its initial product offering comprises 2 minimally-invasive, novel catheter-based mechanical thrombectomy devices. It built its products purposely on the basis of the specific characteristics of the venous system and the treatment of the two distinct indications of venous thromboembolism or VTE (deep vein thrombosis and pulmonary embolism/ PE). Its FlowTriever product is the first thrombectomy system, which is FDA-cleared, used for the treatment of PE. Its advanced systems & processes to control the key relationships between its sales representatives and treating physicians like cardiologists, radiologists, helps it to quickly iterate products, launch and execute physician education and training programs and scale its sales organization. The company markets and sells its products to hospitals across the U.S.

Info & Links

CEO

Andrew Hykes

Headquarters

6001 Oak Canyon, Suite 100
Irvine, CA 92618, UNITED STATES

Auditor

BDO USA, P.C.

Share holders

Employees

1,300

Inari Medical Inc Statistics

Valuation Measures

Market Capitalization²

4.64B

Enterprise Value

4.60B

Enterprise Value/EBITDA(ttm)

-96.20

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

5.07

Price to Book(mrq)

6.98

Price to Cash(ytd)

587.47

Profitability

Gross Margin(ttm)

86.82%

Operating Margin(ttm)

-7.78%

Profit Margin(ttm)

-13.48%

Return on Equity(ttm)

-10.09%

Return on Invested Capital(ttm)

-18.04%

Return on Assets(ttm)

-6.60%

Income Statement

Revenue(ttm)

574.50M

Revenue Per Share(ttm)

9.81

Gross Profit(ttm)

498.76M

EBITDA(ttm)³

-47.80M

Net Income Available to Common(ttm)

-78.58M

Diluted EPS(ttm)

-1.35

Share Statistics

Beta (5Y Monthly)

0.97

52-Week Change

26.25%

S&P 500 52-Week Change

24.42%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

58.54M

Dividend Yield

0.00%

Float⁴

52.34M

% Held by Insiders

10.60%

% Held by Institutions

90.98%

Balance Sheet

Total Cash(mrq)

111.61M

Total Cash Per Share(mrq)

1.91

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.77%

Quick Ratio(mrq)

1.40%

Book Value Per Share(mrq)

7.44

Cash Flow

Operating Cash Flow Per Share(ytd)

0.03

Free Cash Flow(ytd)

-8.26M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

NARI

Inari Medical Inc

Inari Medical Inc Profile